Fresh peripheral blood mononuclear cells exposed to alloantigen for 3-8 d in the presence of anti-CD3 antibodies showed no response after restimulation with cells from the original donor but remained capable of responding to third-party donors . Antigen-specific nonresponsiveness was induced by both nonmitogenic and mitogenic anti-CD3 antibodies but not by antibodies against CD2, CD4, CD5, CD8, CD18, or CD28 . Nonresponsiveness induced by anti-CD3 antibody in mixed leukocyte culture was sustained for at least 34 d from initiation of the culture and 26 d after removal of the antibody. Anti-CD3 antibody also induced antigen-specific nonresponsiveness in cytotoxic T cell generation assays. Anti-CD3 antibody did not induce nonresponsiveness in previously primed cells. Nonresponsiveness induced by anti-CD3 did not appear to be associated with suppressor cell activation . Thus, co-stimulation of the T cell receptor-CD3 complex on unprimed T cells with a fluid phase anti-CD3 antibody and allogeneic major histocompatibility complex antigens can induce either clonal anergy or clonal deletion. These results suggest novel approaches for achieving transplantation tolerance.
Summary
Fresh peripheral blood mononuclear cells exposed to alloantigen for 3-8 d in the presence of anti-CD3 antibodies showed no response after restimulation with cells from the original donor but remained capable of responding to third-party donors . Antigen-specific nonresponsiveness was induced by both nonmitogenic and mitogenic anti-CD3 antibodies but not by antibodies against CD2, CD4, CD5, CD8, CD18, or CD28 . Nonresponsiveness induced by anti-CD3 antibody in mixed leukocyte culture was sustained for at least 34 d from initiation of the culture and 26 d after removal of the antibody. Anti-CD3 antibody also induced antigen-specific nonresponsiveness in cytotoxic T cell generation assays. Anti-CD3 antibody did not induce nonresponsiveness in previously primed cells. Nonresponsiveness induced by anti-CD3 did not appear to be associated with suppressor cell activation . Thus, co-stimulation of the T cell receptor-CD3 complex on unprimed T cells with a fluid phase anti-CD3 antibody and allogeneic major histocompatibility complex antigens can induce either clonal anergy or clonal deletion. These results suggest novel approaches for achieving transplantation tolerance.
Antigen recognition by human T cells is mediated by the 1 -1 ci and S polymorphic chains ofthe TCR, noncovalently associated on the cell surface with a group of five invariant polypeptides designated -y,S,e, and~-r, which collectively represent the CD3 complex responsible for signal transduction (1) . Binding of an antibody to TCR or to CD3 can block T cell responses not merely by steric hindrance of TCR but also by altering cellular function (2, 3) . The effects ofTCRCD3 binding by an antigen presented by an MHC gene product, a physiological solid-phase ligand, differ substantially from the effects ofbinding by a fluid phase ligand, such as a soluble antibody (4). An increase in the concentration of cytoplasmic free calcium and activation of protein kinase C can occur in either case, but Ilr2 receptor expression is induced only with solid-phase ligands (4-6). Activation of the IIr2 gene requires TCRCD3 binding by a solid-phase ligand together with certain other signals provided by accessory cells (7, 8) . Soluble factors such as IIrl and cell-cell interactions mediated through CD2, CD5, CD28, LFA1, and MHC class I molecules can function as accessory activation signals (7) (8) (9) . In the absence of such signals, it has been observed in type I murine T cell clones that solid-phase binding to TCRCD3 induces anergy to further stimulation by specific antigen (reviewed in references 10, 11) and IIr2 (12) .
After binding of fluid phase antibody, the TCRCD3-ligand complex undergoes receptor-mediated endocytosis (4, 13, 14), but after binding of a solid-phase ligand internalization of the TCRCD3 complex does not occur. The process of internalization, also referred to as modulation, is energy-dependent and appears to be regulated by the state of phosphorylation ofthe CD3,y subunit (15) . After TCRCD3 modulation, T cells become refractory to restimulation with specific antigen, PHA, Con A, or to signals delivered through CD2, CD5, and CD28 (4, [16] [17] [18] . Reappearance of responsiveness, however, parallels reexpression of TCR-CD3 on the cell surface (16) . In this report, we demonstrate that co-stimulation of unprimed human T cells with soluble anti-CD3 antibody and allogeneic MHC can induce a sustained state of antigenspecific nonresponsiveness.
Materials and Methods
PrimaryMixedLeukocyte Culture PBMC were prepared by density gradient centrifugation on Ficoll-Hypaque. PBMC were resuspended in medium containing RPMI 1640, 25 mM Hepes, 1 U/ml penicillin, 1 jig/ml streptomycin, and 10% pooled human serum that had been heat inactivated at 56°C for 30 min. Responder A and stimulators B and C were unrelated individuals chosen so that there was at least one HLA class I and one HLA-DR antigen mismatched between A and B, and A and C. Stimulator cell donors B and C did not share HLA-DR, DO, or DP antigens . 5 x 104 responder cells were mixed with 5 x 104 irradiated stimulator cells (3,000 rad) in round-bottomed 96-well plates . In certain experiments antibody containing medium was dispensed first, followed in sequence by responc]cr ahd stimulator cells. Plates were cultured at 37°C in a 5% C02 atmosphere. Assays were performed in triplicate. Cultures were pulsed with one WCi of [3H]thymidine 18 h before harvesting. 10 replicate plates were set up and one was harvested each day for 10 consecutive days. Data are reported as mean counts per minute of the three replicates .
Restimulation Assays. 10' PBMC from one individual were primed with an equivalent number of irradiated (3,000 rad) PBMC from another HLA class I and II incompatible individual in 25-cmz flasks, using identical medium and culture conditions as for primary MLC carried out in 96-well plates . Cells were cultured for 12 d before harvesting unless specified otherwise. For blocking experiments, cells were cultured for 8 d in the presence of antibody, washed three times, recultured in medium without antibody for four additional days, harvested on day 12, and then restimulated . In experiments of tertiary stimulation, a secondary culture was carried out in flask, as in the first. For assay, 2 x 104 primed responders and 5 x 104 irradiated stimulators were incubated in 96-well round-bottomed wells in medium without antibody. Assays were performed as detailed for primary MLC. Percent control response of antibody-treated cells was calculated by the formula: 100 x [cpm
, where: a is allogeneic MLR, /3 is autologous MLR, E is experimental antibody, and C is control antibody.
Suppression Assays. Lymphocytes were primed as described for use in restimulation assays . On day 12, primed cells were irradiated with 1,500 rad and tested as regulators in a primary MLC. 10r egulators were mixed with 5 x 104 fresh autologous responder PBMC and 5 x 104 irradiated (3,000 rad) stimulators per well . Proliferation was measured daily for 10 d. The response to irradiated autologous stimulators was consistently <2% of the response of allogeneic stimulators and was not affected by primed regulators. Percent inhibition was calculated by the formula: 100 x [cpm (responder + stimulator,; + regulator.)]/ [cpm (responder + stimulator.)] Generation of CTL. Freshly separated PBMC or primed lymphocytes were tested for CTL precursor activity by priming in a modified MLC. Responder cells (107) either fresh or primed as specified for each experiment, and irradiated stimulator cells (107), were cultured for 6 d, harvested, washed twice, and tested for cytolytic effector activity in a 4-h "Cr-release assay against PHA blasts. Both autologous or stimulator lymphocytes were tested as target cells. Maximum and spontaneous release values were obtained by incubating targets with 1% Triton-X 100 and medium alone, respectively.Triplicate assays were carried out at E/T ratio of 10 :1, 50 :1, 100:1 in V-bottomed 96-well plates . Data are reported as mean percent specific "Cr release.
Antibodies. Murine mAbs used in this study are listed in Table  1 . Antibodies WT31(anti-CD3-a/0 complex), X39 and X40 (anti-KLH), and 2A3 (anti-CD25) were obtained from Becton Dickinson (San Jose, CA). Antibodies 1A12 and Tl1D7 (Anti-murine Thy-1.1) were kindly provided by Dr. Irv Bernstein (Fred Hutchinson Cancer Research Center, Seattle, WA). All other antibodies were produced in our laboratory and were previously described (see references [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] Taken together, these data suggest that BC3, 64.1, and 38 .1 bind to closely associated but distinct epitopes expressed on the CD3 complex. The specificity of antibody BC18 for CD2 was determined by immunoprecipitating a 50,000 M species from "6I-labeled PBMC and by blocking lymphocyte adhesion to sheep erythrocytes. Before use in functional studies, mAbs were purified from ascites fluids by precipitation with 50% saturated ammonium sulfate followed by DEAE-Sephacryl chromatography (Pharmacia Fine Chemicals, Piscataway, NJ) or by affinity chromatography on Sepharose-bound protein A. Purified antibodies were dialyzed against PBS and filter sterilized . Immunofluorescence Analyses. Surface expression of the CD3 complex or the CD3-associated TCR-a/0 complex was quanti- 
Results
Induction ofAntigen-spec fic Nonresponsiveness by Anti-CD3 . Fresh human PBMC were incubated for 1 h at 37°C with 10,ug/ml of either the anti-CD3 murine IgG2b mAb BC3 or a nonbinding antibody of irrelevant specificity. The antibody-treated PBMC were then mixed with irradiated, HLA-incompatible stimulator cells and cultured in the continuous presence of antibody. Antibody BC3 did not induce proliferation ofcells cultured with irradiated autologous stimulators (data not shown) and inhibited completely the proliferative response of cells stimulated with allogeneic stimulators from two different donors (Fig. 1, top panels) . To evaluate effect o£ antibody BC3 on secondary responses, lymphocytes were cultured with alloantigen for 8 d in separate flasks in medium containing BC3 or control antibody. Cells were then washed to remove antibody, cultured in fresh medium for an additional 4 d to allow reexpression ofthe CD3-TCR complex (as demonstrated in Fig. 2) , and then restimulated with irradiated PBMC from either the original donor (Fig. 1, left bottom pane or from a third-party donor (Fig. 1 , right bottom pane in medium containing no antibody. Cells primed in the presence of control antibody (closed symbols) and restimulated with PBMC from the donors originally used for priming showed a typical accelerated secondary proliferative response, peaking on day 3. In contrast, those same primed cells showed a typical primary response, peaking on day 6, when stimulated with PBMC from a third-party donor. Cells primed TCR-a//3 in the presence of antibody BC3 (open symbols), however, showed no detectable response when challenged with PBMC from the original donor, yet responded normally to PBMC from a third-party donor. The degree of proliferation observed in secondary MLC correlated with the concentration of antibody BC3 in the primary cultures, with 93% inhibition achieved at 10 jAg/ml, and 73% inhibition at 1 14g/ml (data not shown) . These results demonstrate that the secondary proliferative response of human T cells can be inhibited in an antigen-specific manner when the primary culture with alloantigen occurs in the presence of antibody BC3 at a concentration of 10 1~g/ml . To assess whether the ability to induce alloantigen-specific nonresponsiveness was unique for antibody BC3, other anti-CD3 antibodies were tested in identical assays. Antibody 38.1 is a murine IgM anti-CD3 antibody that is not mitogenic for human PBMC unless bound to a solid-phase matrix. Antibody 38.1 inhibited primary MLR by 85% when compared with a control antibody of irrelevant specificity ( Table 2 , line 2). Furthermore, cells exposed to alloantigen in primary MLC in the presence of antibody 38.1 demonstrated a decreased response to the specific antigen in restimulation assay, as low (Table 2 , lines 4, 5, and 6) but had no effect on kinetics or magnitude of subsequent secondary proliferative responses to specific or third-party alloantigens in absence of antibody. Anti-CD28 antibody 9.3 and anti-CD4 antibody 66.1 inhibited primary MLR by 66% and 44%, respectively, but had no effect on secondary proliferative responses in the absence of antibody (Table 2 , lines 7 and 8) . Anti-CD5 antibody 10.2 and anti-CD8 antibody 51.1 did not inhibit primary or secondary MLR (Table 2, lines 9 and 10). Taken together, these data indicate that anti-CD3 antibodies are unique in their ability to induce nonresponsiveness to restimulation with specific alloantigen in secondary cultures .
Duration ofAntigen-specific Nonresponsiveness Induced by Anti-CD3. To assess the duration of alloantigen-specific nonresponsiveness, cells were exposed to alloantigen in medium containing BC3 or control antibody, washed on day 8, and cultured in fresh medium without antibody or alloantigen for 4, 11, or 18 d. These cells were restimulated on days 12, 19, and 26, respectively, after initiation of the primary culture. At all time points, cells primed in medium containing control antibody showed a typical accelerated proliferative response, peaking on day 3, when restimulated with irradiated PBMC from the donor originally used for priming and showed a typical primary response, peaking on day 6, when restimulated with irradiated PBMC from a third-party donor (Fig. 3) . In contrast, cells primed in the presence of anti-CD3 antibody did not respond when stimulated with irradiated PBMC from the original donor but remained capable ofresponding to cells ofa third-party donor. These data demonstrate that the nonresponsive state induced by exposure to alloantigen in the presence of antibody BC3 appears to last for at least 34 determine the duration of exposure to anti-CD3 necessary for development of nonresponsiveness, cells were washed on days 1, 3, 5, or 7 of primary MLC, resuspended in fresh medium without antibody, and rested until day 12 when they were restimulated with irradiated PBMC from the original donor or from a third-party donor. Primary MLC in the presence of antibody BC3 for 3, 5, or 7, but not for 1 d, produced nonresponsiveness in secondary cultures stimulated with irradiated PBMC from the original donor and had no effect on the response to irradiated PBMC from third-party donors . Primary MLC carried out with antibody BC3 for 1 d had diminished the magnitude of the secondary response to 68% of the control (Fig. 4) . Thus, it appears that the minimum time of exposure to antibody BC3 needed to induce alloantigen-specific nonresponsiveness in MLC is between 1 and 3 d. Effect ofAnti-CD3 on CTL Generation. Disparity for MHC class II antigens induces proliferation of allogeneic T cells in MLC, while disparity for MHC class I antigens induces Table 3 . Effect of Anti-CD3 mAb on Generation ofCells with Suppressive Activity (Fig. 5, right) . In contrast, cells primed in the presence of antibody BC3 (open symbols) did not generate cytotoxic activity when restimulated with cells from the original donor but remained capable of generating cytotoxic activity when restimulated with cells from the third-party donor. Thus, findings in the cytotoxicity assay paralleled those seen in the proliferative assays . Effect ofAnti-CD3 on Responsiveness ofPrimed Cells. Further experiments were undertaken to determine whether alloantigen-specific nonresponsiveness could be induced in primed cells. For these experiments, cells were primed in a 12-d MLC in medium containing no antibody (Fig. 6, top panel) . Primed cells were then incubated with BC3 or control antibody for 1 h at 37°C, and restimulated with cells from the donor originally used for priming. Antibody BC3 completely inhibited the secondary proliferative response (Fig. 6, middle panel) . In separate cultures, primed cells were restimulated in the presence of BC3 or control antibody for 8 d, then washed and rested for four additional days. Cells were then assayed in a tertiary MLR . Antibody BC3 had had no effect on responsiveness ofprimed cells to restimulation with specific antigen (Fig. 6, bottom panel) . Thus, induction of nonresponsiveness by antibody BC3 was seen only in unprimed and not in primed cells.
Effect of Anti-CD3 on Generation of Cells with Suppressive Activity. During an in vitro MLC, certain cells acquire antigen-specific suppressive activity (33) . This can be demonstrated by a reduced proliferation when primed irradiated cells are added to fresh autologous responders stimulated with specific alloantigen. Suppressive activity is increased if the priming MLC is carried out in the presence of cyclosporine or antibodies binding to the IIr2 receptor (34, 35) . We investigated whether cells primed to specific antigen in the presence of antibody BC3 had acquired this type of suppressive activity. Cells recovered from primary MLC carried out in the presence of antibody BC3 were irradiated and added as regulators in a fresh MLC. Cells primed in the presence of the anti ID2 receptor light chain antibody 2A3 (CD25) at 10 Ag/ml or cyclosporine A at 0.5 ug/ml suppressed the Primary cultures were performed in medium containing 10 Kg/ml 9E8 (control), BC3 (anti-CD3), 2A3 (anti-CD25), or 0.5 ug/ml cyclosporine A (CYA), mixing responder cells from one individual with irradiated stimulator cells from HLA incompatible donors A or B. Primed cells were irradiated (1,500 rad) and tested as regulators in a fresh MLC. 1sH]thymidine uptake was measured daily for 10 d and cpm values at peak response were used to calculate percent inhibition as described in Materials and Methods. No significant differences in response kinetics were observed for antibody or CYA treated cultures (data not shown) .
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Anti-CD3 and Antigen Induce Specific Nonresponsiveness in Human T Cells proliferative response of fresh autologous lymphocytes stimulated with specific alloantigen but had no effect on the response to alloantigen from third party donors (Table 3) . In contrast, cells primed in control cultures with an antibody of irrelevant specificity had little specific suppressive activity. Cells primed in the presence of anti-CD3 also showed little specific suppressive activity. Thus, nonresponsiveness induced by anti-CD3 antibody was not likely the result of activation of a radiation-resistant suppressor cell.
Discussion
Our study demonstrates that co-stimulation with a soluble anti-CD3 antibody and alloantigen can induce a sustained state of specific nonresponsiveness in unprimed human T cells. One possible interpretation of this phenomenon is that modulation of the TCR CD3 complex by a high concentration of soluble anti-CD3 antibody can condition T cells to become anergic in response to allogeneic MHC, a process that might be similar to induction of anergy by excess antigen (36, 37) . We demonstrated nonresponsiveness in both proliferative as well as CTL generation assays, suggesting that anti-CD3 antibodies can condition the response of more than one type of T cell to both MHC class I and class II alloantigens. Lack of CTL generation, however, might merely reflect the absence of helper activity and does not necessarily indicate nonresponsiveness to MHC class I antigens.
Nonresponsiveness was inducible only by antibodies specific for CD3 and not by antibodies to other T cell surface molecules . LFA-1 (CD11/CD18) and LFA 2 (CD2) are surface receptors mediating antigen-independent intercellular adhesion by binding to their respective ligands ICAM-1/2 and LFA-3 expressed on a variety of all types. LFA1 and LFA-2 or associated structures, are capable of signal transduction since antibodies to LFA1 and LFA2 not only can block cell adhesion but also effect a variety of other cellular functions . We have confirmed that anti-LFA1 and anti-LFA2 antibodies inhibit primary MLR, but this does not affect the pattern of secondary response to specific antigen. Results ofanti-LFA1 and LFA2 blocking experiments suggested that T cell memory can be induced with little or no DNA synthesis. Thus, it would seem unlikely that nonresponsiveness induced by anti-CD3 antibodies results solely from insufficient cellular proliferation during primary antigen exposure.
The culture conditions we used were favorable for allowing sustained T cell viability and function as measured by responses to alloantigens for up to 26 d after initiation of the primary culture. Nonresponsiveness to restimulation by the priming antigen did not likely result from failure to reexpress the TCR CD3 complex, since cells showed a uniform pattern ofTCR and CD3 surface reexpression, that had returned to control levels within 3 d ofculture in absence ofanti-CD3 antibody. Lack of TCRCD3 reexpression on the small population of clones specific for the priming antigens, however, could not be excluded by our assay. We also attempted to rule out that nonresponsiveness to the priming antigen was secondary to activation of suppressor cells, which occurs in MLC. Cells 169 7 Anasetti et al .
able to suppress the proliferative response of unprimed autologous PBMC against specific alloantigen can be preferentially activated in MLC carried out in the presence of cyclosporine A or antibodies to the IIr2R 55-kD chain (34, 35) . Cells exposed to anti-CD3 and alloantigen were nonresponsive to restimulation in secondary MLC, but had no detectable suppressive effect when added to autologous responder PBMC in a fresh MLC against specific alloantigen. By a process of elimination, we suggest that T cell nonresponsiveness induced by anti-CD3 antibody is likely the result of clonal anergy or death . The MLC model cannot distinguish these two possibilities . Use ofnonmitogenic murine anti-CD3 antibodies was essential to achieve the results shown . Mitogenic anti-CD3 antibodies also induced nonresponsiveness, although culture with mitogenic anti-CD3 yielded lower cell viability, which might in part account for the decreased secondary response against cells from third-party donors. In addition, mitogenic anti-CD3 antibodies by themselves might induce generalized T cell hyporesponsiveness, as demonstrated by in vitro and in vivo experiments in murine systems (11, 38). The mitogenic activity of anti-CD3 antibodies depends on their heavy chain isotype (39) . Since Fc receptors on accessory cells provide a matrix for multimeric binding of anti-CD3 antibodies, and since crosslinking of CD3 molecules is one of the requirements for induction of DNA synthesis in T cells, the affinity of Fc receptors on accessory cells for the Fc domain of anti-CD3 antibodies represents an important determinant of T cell activation. Fc receptors types I (CD64) are permissive for the mitogenic activity of murine IgG2a and IgG3 anti-CD3 antibody (31), while Fc receptors type II (CD32) are permissive for murine IgG1 anti-CD3 antibodies (40) . Fc receptors type II on monocytes and B cells bind aggregated murine IgG2b immunoglobulins, but this does not lead to mitogenic activity, even though anti-CD3 IgG2b antibodies are mitogenic when bound to a solid-phase support (40) . This may reflect the high flexibility of the hinge region ofmurine IgG2b immunoglobulins that allows the bound antigen to move in multiple directions (41) .
The functional consequences of ligand. binding to TCR-CD3 depend both on the physical properties of the interaction and the state of differentiation and activation of the T cell. In immature thymocytes and in certain T cell tumor lines, crosslinking TCR CD3 induces an increase in cytoplasmic free calcium followed by RNA and protein synthesis (42) . Cells increase in size but are blocked in progression through the cell cycle at the interface between GI and S (43). Activation of a calcium dependent endonuclease causes DNA fragmentation and cell death, a phenomenon known as apoptosis (44) (45) (46) (47) (48) (49) (50) (51) . It has been suggested that clonal deletion of autoreactive T cells in the thymus may occur by a similar process (52) . Variants ofa murine T cell hybridoma expressing normal amounts of CD3r2 but decreased amounts of CD3rq demonstrated little activation ofa serine-specific protein kinase that phosphorylates CD3y (45) . In contrast to the parental line, the variants did not undergo programmed cell death after CD3 crosslinking (50) . In this and in another model (53) , the biological responses ofT cells seemed to depend on the composition of the TCRCD3 complex . In view of this observation, it is attractive to question whether the TCR-CD3 complex on human T cells undergoes structural changes after a soluble anti-CD3 has induced internalization of the TCR-CD3-ligand complex.
In contrast to lymphocytes freshly separated from peripheral blood, we could not induce nonresponsiveness in T cells previously primed in vitro. Profound differences have been identified between "naive" and "memory" T cells (54) . Memory T cells can be distinguished by their increased expression of LFA If this were the case, T cells bound by soluble anti-CD3 would lack adhesion structures for accessory cells. Thus, there would be a similarity between nonresponsiveness induced by anti-CD3 antibody and the anergy occurring in type 1 murine T cell clones after solid-phase ligand binding to TCRCD3 in absence of accessory signals (10) . Alternatively, the ability to induce nonresponsiveness in naive T cells but not in memory T cells may reflect differences in the structure of the TCR-CD3 complex or in the types of signals transduced.
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